You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The funding will help the company further develop its INSPECTR molecular diagnostic platform into a test that can be used in various settings.
Two new grants are helping the company develop its SHERLOCK and INSPECTR technologies as the basis for creating innovative diagnostics.
